Next Article in Journal
Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis
Previous Article in Journal
Improving the Dosing Schedules of Targeted Anticancer Agents
Previous Article in Special Issue
Evaluating TnP as a Potential Therapeutic Agent for Retinopathy in Zebrafish Models
 
 
Case Report

Article Versions Notes

Pharmaceuticals 2025, 18(6), 849; https://doi.org/10.3390/ph18060849
Action Date Notes Link
article xml file uploaded 6 June 2025 12:00 CEST Original file -
article xml uploaded. 6 June 2025 12:00 CEST Update -
article pdf uploaded. 6 June 2025 12:00 CEST Version of Record https://www.mdpi.com/1424-8247/18/6/849/pdf-vor
article html file updated 6 June 2025 12:03 CEST Original file -
article xml file uploaded 10 June 2025 03:18 CEST Update -
article xml uploaded. 10 June 2025 03:18 CEST Update https://www.mdpi.com/1424-8247/18/6/849/xml
article pdf uploaded. 10 June 2025 03:18 CEST Updated version of record https://www.mdpi.com/1424-8247/18/6/849/pdf
article html file updated 10 June 2025 03:20 CEST Update https://www.mdpi.com/1424-8247/18/6/849/html
Back to TopTop